COVID-19: Sovereign Pharma dispatches first batch of generic remdesivir to Cipla Ruchika Sharma8 July 2020 1:15 PM ISTAt current capacity, the Sovereign can supply 50,000 to 95,000 vials per month of the injectable, the company said in an emailed statement on Tuesday.
Cipla, Boehringer Ingelheim to co-market oral anti-diabetic drugs Oboravo, Oboravo Met, Tiptengio Ruchika Sharma30 Jun 2020 11:28 AM ISTThe Indian diabetes market is valued at INR 1,45,451 million and is growing at 10.35% (IMS MAT May 2020) with the oral anti-diabetic market being...
Cipla to knock out Hetero Healthcare in pricing battle of Remdesivir? Farhat Nasim29 Jun 2020 5:13 PM ISTNew Delhi: Igniting drug pricing battle among pharmaceutical majors, Drug major, Cipla Ltd., has priced antiviral drug Remdesivir at under Rs...
Covid-19 Drug: Cipla to price generic version of Remdesivir at less than Rs 5000 Ruchika Sharma24 Jun 2020 11:55 AM ISTHetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees.
CDSCO reviewing Cipla, Dr Reddys, others applications for Remdesivir on priority: Health Ministry Ruchika Sharma15 Jun 2020 4:00 PM ISTThe CDSCO is awaiting the data and is providing complete support to these companies. It has already waived off the requirement of local clinical...
Combating COVID-19: India to soon begin domestic production of Remdesivir drug Farhat Nasim14 Jun 2020 10:15 AM IST"Pharma companies have been directed to conduct Active-Post Marketing Surveillance of each case and prepare a report on the benefit or recovery of a...
Cipla becomes 2nd firm to enter tie-up with Gilead to make remdesivir in India MD Bureau13 May 2020 9:23 AM ISTCipla will be permitted to manufacture the active pharmaceutical ingredient (API) and finished product, and market it in 127 countries including India...
